CXCL9 and cancer: Similar to the pan-cancer analysis, LRP2 mutations had high TMB, MSI and immune cell infiltration in EC and also leaded to high expression of immune-related genes, such as CXCL9, CXCR6, CXCL13, ICOS and immune checkpoint genes (CTLA4 and LAG3).